CTOs on the Move

Novation

www.novationco.com

 
Founded in 1998, Novation is the leading health care supply chain expertise, analytics and contracting company for the more than 100,000 members of VHA Inc. and UHC, two national health care alliances, Children's Hospital Association, an alliance of the nation's leading pediatric facilities, and Provista, LLC. Novation provides alliance members with sourcing services, as well as information and data services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC, Children’s Hospital Association, and Provista members used Novation contracts to purchase more than $43 billion in 2012.
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

American Health Care

American Health Care is a San Bernardino, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Darin M. Camarena Health Center

Darin M. Camarena Health Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Madera, CA. To find more information about Darin M. Camarena Health Center, please visit www.camarenahealth.org

Healthcall

Healthcall is a Southfield, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mahaska Health Partnership

Mahaska Health Partnership is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Oskaloosa, IA. To find more information about Mahaska Health Partnership, please visit www.mahaskahealth.org

ASCENDIS PHARMA

Ascendis Pharma is focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs with new patent life. Our proprietary TransCon platform is the leading, most versatile transient conjugation technology and is utilized to create clinically superior prodrugs in therapeutic areas characterized by high unmet medical need. TransCon technology creates novel long acting prodrugs of proteins, peptides and small molecules, suitable for either local or systemic treatment. Ascendis Pharma has a diversified and balanced high-value pipeline, including internal programs and partnerships together with market leaders on their key projects.